Ozempic Could Get Way Too Expensive Under Trump—Here's What You Can Do
While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.
NBC 6 South Florida14d
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
Both Novo Nordisk and Eli Lilly's current weight loss treatments are administered via injection, but oral formats are considered the next frontier in expanding patient accessibility. "We actually ...
Euronews14d
Novo Nordisk shares surge as weight loss treatments boost profits
Europe's largest pharmaceutical firm, Novo Nordisk, reported fourth-quarter earnings that surpassed analysts' expectations. The company’s shares jumped more than 6% at the market open in Europe ...
RTE Online14d
Novo Nordisk sees slower sales growth in 2025
Obesity drug maker Novo Nordisk has forecast slower growth this year after Wegovy sales more than doubled in the final quarter of 2024, with analysts and investors describing the results as "good ...
Morningstar14d
Novo Nordisk Expects Slowing Sales Growth This Year — Update
Novo Nordisk expects sales growth to slow this ... that it hopes will accelerate weight-loss and boost other areas of patient health. Data from a keenly-anticipated trial of its CagriSema drug ...
The Globe and Mail14d
Wegovy sales double to boost Novo Nordisk’s fourth quarter as growth set to slow
Obesity drug maker Novo Nordisk NVO-N forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, with analysts and investors describing the results as “good ...
BioSpace14d
Novo Nordisk’s sales increased by 25% in Danish kroner and by 26% at constant exchange rates to DKK 290.4 billion in 2024
which can be found under ‘Investors’ (the contents of the company’s website do not form a part of this Form 6-K). Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered ...
Yahoo15d
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
Telehealth company Hims & Hers has had enough—and is putting its money where its mouth is in the form of its first ... products aren’t FDA-approved. Novo Nordisk has nominated semaglutide ...
Nasdaq18d
See Which Of The Latest 13F Filers Holds Novo-Nordisk
At Holdings Channel, we have reviewed the latest batch of the 22 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Novo-Nordisk AS (Symbol: NVO) was held by 9 of these ...
Insider Monkey19d
Jim Cramer on Novo Nordisk A/S (NVO): ‘They Don’t Have The Production Capability’
In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks Jim Cramer recently talked about. Jim Cramer, the host of Mad Money, has been ...
The Financial Express20d
USFDA gives nod to Novo Nordisk’s Ozempic to reduce risk of kidney failure
(Image Credits: Pixabay) The United States Food and Drug Administration (USFDA) has approved Novo Nordisk’s Ozempic for reducing the risk of kidney failure and disease progression. According to ...